Novel prognostic marker PRMT1 regulates cell growth via downregulation of CDKN1A in HCC

Hepatocellular carcinoma (HCC) is a major type of liver cancer caused by the hepatitis B and C viruses, alcohol and exposure to aflatoxin. For HCC treatment, anticancer drugs have been widely used, but drug resistance in advanced HCC is an important problem, resulting in a continuous need for novel...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncotarget
Egile Nagusiak: Ryu, Jea-Woon, Kim, Seon-Kyu, Son, Mi-Young, Jeon, Su-Jin, Oh, Jung-Hwa, Lim, Jung Hwa, Cho, Sunwha, Jung, Cho-Rok, Hamamoto, Ryuji, Kim, Dae-Soo, Cho, Hyun-Soo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Impact Journals LLC 2017
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5777784/
https://ncbi.nlm.nih.gov/pubmed/29383172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23296
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak